Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Zukerberg LR |
Year: |
2000 |
Journal: |
Neuron |
Title: |
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. |
Volume: |
26 |
Issue: |
3 |
Pages: |
633-46 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6452989 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2020-09-04 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:3271125 |
Pattern: |
Not Specified |
Stage: |
TS25 |
Assay Id: |
MGI:6452991 |
Age: |
embryonic day 17.5 |
|
|
Specimen Label: |
1A Cdk5 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6452989 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2020-09-04 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3271225 |
Pattern: |
Widespread |
Stage: |
TS25 |
Assay Id: |
MGI:6452991 |
Age: |
embryonic day 17.5 |
|
|
Specimen Label: |
1A Cdk5 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6452989 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2020-09-04 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270725 |
Pattern: |
Not Specified |
Stage: |
TS25 |
Assay Id: |
MGI:6452991 |
Age: |
embryonic day 17.5 |
|
|
Specimen Label: |
1A Cdk5 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
Publication |
First Author: |
Utreras E |
Year: |
2013 |
Journal: |
Neurochem Int |
Title: |
Cdk5 regulates Rap1 activity. |
Volume: |
62 |
Issue: |
6 |
Pages: |
848-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Posada-Duque RA |
Year: |
2017 |
Journal: |
Cell Mol Life Sci |
Title: |
CDK5 downregulation enhances synaptic plasticity. |
Volume: |
74 |
Issue: |
1 |
Pages: |
153-172 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ouyang L |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
p39-associated Cdk5 activity regulates dendritic morphogenesis. |
Volume: |
10 |
Issue: |
1 |
Pages: |
18746 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lagace DC |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Cdk5 is essential for adult hippocampal neurogenesis. |
Volume: |
105 |
Issue: |
47 |
Pages: |
18567-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun KH |
Year: |
2008 |
Journal: |
J Neurochem |
Title: |
Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. |
Volume: |
107 |
Issue: |
1 |
Pages: |
265-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Benavides DR |
Year: |
2007 |
Journal: |
J Neurosci |
Title: |
Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. |
Volume: |
27 |
Issue: |
47 |
Pages: |
12967-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang KH |
Year: |
2011 |
Journal: |
Mol Biol Cell |
Title: |
Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. |
Volume: |
22 |
Issue: |
9 |
Pages: |
1452-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao C |
Year: |
2002 |
Journal: |
Mol Cancer Res |
Title: |
CDK5 regulates cell adhesion and migration in corneal epithelial cells. |
Volume: |
1 |
Issue: |
1 |
Pages: |
12-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Furusawa K |
Year: |
2017 |
Journal: |
J Neurosci |
Title: |
Cdk5 Regulation of the GRAB-Mediated Rab8-Rab11 Cascade in Axon Outgrowth. |
Volume: |
37 |
Issue: |
4 |
Pages: |
790-806 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheung ZH |
Year: |
2007 |
Journal: |
PLoS Biol |
Title: |
Cdk5 is involved in BDNF-stimulated dendritic growth in hippocampal neurons. |
Volume: |
5 |
Issue: |
4 |
Pages: |
e63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pallari HM |
Year: |
2011 |
Journal: |
Mol Biol Cell |
Title: |
Nestin as a regulator of Cdk5 in differentiating myoblasts. |
Volume: |
22 |
Issue: |
9 |
Pages: |
1539-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu WY |
Year: |
2007 |
Journal: |
Nat Neurosci |
Title: |
Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. |
Volume: |
10 |
Issue: |
1 |
Pages: |
67-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee DK |
Year: |
2019 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Cdk5 regulates N-cadherin-dependent neuronal migration during cortical development. |
Volume: |
514 |
Issue: |
3 |
Pages: |
645-652 |
|
•
•
•
•
•
|
Publication |
First Author: |
Utreras E |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons. |
Volume: |
287 |
Issue: |
20 |
Pages: |
16917-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zheng YL |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. |
Volume: |
11 |
Issue: |
8 |
Pages: |
e0160252 |
|
•
•
•
•
•
|
Publication |
First Author: |
Plattner F |
Year: |
2014 |
Journal: |
Neuron |
Title: |
Memory enhancement by targeting Cdk5 regulation of NR2B. |
Volume: |
81 |
Issue: |
5 |
Pages: |
1070-1083 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jessberger S |
Year: |
2008 |
Journal: |
PLoS Biol |
Title: |
Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus. |
Volume: |
6 |
Issue: |
11 |
Pages: |
e272 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
Pattern: |
Not Specified |
Stage: |
TS19 |
Assay Id: |
MGI:6189950 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - Cdk5 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:6189950 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - Cdk5 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
Pattern: |
Not Specified |
Stage: |
TS24 |
Assay Id: |
MGI:6189950 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - Cdk5 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:6189950 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - Cdk5 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189950 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Cdk5 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189950 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Cdk5 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6169530 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189950 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Cdk5 |
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1822
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
NavaneethaKrishnan S |
Year: |
2020 |
Journal: |
Oncogene |
Title: |
mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca2+ uptake. |
Volume: |
39 |
Issue: |
13 |
Pages: |
2797-2806 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hernandez A |
Year: |
2016 |
Journal: |
Sci Rep |
Title: |
Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum. |
Volume: |
6 |
|
Pages: |
29812 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang P |
Year: |
2015 |
Journal: |
Nat Commun |
Title: |
S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength. |
Volume: |
6 |
|
Pages: |
8665 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chow HM |
Year: |
2014 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
CDK5 activator protein p25 preferentially binds and activates GSK3β. |
Volume: |
111 |
Issue: |
45 |
Pages: |
E4887-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Niethammer M |
Year: |
2000 |
Journal: |
Neuron |
Title: |
NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. |
Volume: |
28 |
Issue: |
3 |
Pages: |
697-711 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jahani-Asl A |
Year: |
2015 |
Journal: |
Hum Mol Genet |
Title: |
CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death. |
Volume: |
24 |
Issue: |
16 |
Pages: |
4573-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Han SH |
Year: |
1999 |
Journal: |
Neuroscience |
Title: |
Comparison of munc-18 and cdk5 expression in the nervous system during mouse embryogenesis. |
Volume: |
94 |
Issue: |
3 |
Pages: |
955-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang X |
Year: |
2020 |
Journal: |
Cell Mol Neurobiol |
Title: |
Downregulation of CDK5 Restores Sevoflurane-Induced Cognitive Dysfunction by Promoting SIRT1-Mediated Autophagy. |
Volume: |
40 |
Issue: |
6 |
Pages: |
955-965 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rakić S |
Year: |
2015 |
Journal: |
Cereb Cortex |
Title: |
Cdk5 phosphorylation of ErbB4 is required for tangential migration of cortical interneurons. |
Volume: |
25 |
Issue: |
4 |
Pages: |
991-1003 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guan JS |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Cdk5 is required for memory function and hippocampal plasticity via the cAMP signaling pathway. |
Volume: |
6 |
Issue: |
9 |
Pages: |
e25735 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meyer DA |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. |
Volume: |
105 |
Issue: |
47 |
Pages: |
18561-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Demetrick DJ |
Year: |
1994 |
Journal: |
Cytogenet Cell Genet |
Title: |
Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. |
Volume: |
66 |
Issue: |
1 |
Pages: |
72-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miyamoto Y |
Year: |
2007 |
Journal: |
J Cell Sci |
Title: |
Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin. |
Volume: |
120 |
Issue: |
Pt 24 |
Pages: |
4355-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin S |
Year: |
2008 |
Journal: |
FEBS Lett |
Title: |
CDK5 activator p35 downregulates E-cadherin precursor independently of CDK5. |
Volume: |
582 |
Issue: |
8 |
Pages: |
1197-202 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu AK |
Year: |
2001 |
Journal: |
Nat Neurosci |
Title: |
Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. |
Volume: |
4 |
Issue: |
4 |
Pages: |
374-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Horiuchi Y |
Year: |
2006 |
Journal: |
Genes Cells |
Title: |
Identifying novel substrates for mouse Cdk5 kinase using the yeast Saccharomyces cerevisiae. |
Volume: |
11 |
Issue: |
12 |
Pages: |
1393-404 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2010 |
Journal: |
J Neurosci |
Title: |
Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. |
Volume: |
30 |
Issue: |
15 |
Pages: |
5219-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Antoniou X |
Year: |
2011 |
Journal: |
Brain Res |
Title: |
Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism? |
Volume: |
1381 |
|
Pages: |
1-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liebl J |
Year: |
2015 |
Journal: |
Nat Commun |
Title: |
Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2. |
Volume: |
6 |
|
Pages: |
7274 |
|
•
•
•
•
•
|
Publication |
First Author: |
Odajima J |
Year: |
2011 |
Journal: |
Dev Cell |
Title: |
Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. |
Volume: |
21 |
Issue: |
4 |
Pages: |
655-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hirasawa M |
Year: |
2004 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects. |
Volume: |
101 |
Issue: |
16 |
Pages: |
6249-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shu Y |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity. |
Volume: |
11 |
Issue: |
3 |
Pages: |
e0149739 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2014 |
Journal: |
Exp Cell Res |
Title: |
High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway. |
Volume: |
326 |
Issue: |
2 |
Pages: |
219-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cruz JC |
Year: |
2003 |
Journal: |
Neuron |
Title: |
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. |
Volume: |
40 |
Issue: |
3 |
Pages: |
471-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao CY |
Year: |
2004 |
Journal: |
J Cell Sci |
Title: |
Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. |
Volume: |
117 |
Issue: |
Pt 18 |
Pages: |
4089-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nguyen MD |
Year: |
2001 |
Journal: |
Neuron |
Title: |
Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. |
Volume: |
30 |
Issue: |
1 |
Pages: |
135-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu XX |
Year: |
2020 |
Journal: |
J Exp Med |
Title: |
Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. |
Volume: |
217 |
Issue: |
1 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Lin L |
Year: |
2006 |
Journal: |
Cell Death Differ |
Title: |
p53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death. |
Volume: |
13 |
Issue: |
1 |
Pages: |
141-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Na YR |
Year: |
2015 |
Journal: |
Sci Signal |
Title: |
The early synthesis of p35 and activation of CDK5 in LPS-stimulated macrophages suppresses interleukin-10 production. |
Volume: |
8 |
Issue: |
404 |
Pages: |
ra121 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. |
Volume: |
105 |
Issue: |
25 |
Pages: |
8772-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tong C |
Year: |
2023 |
Journal: |
Research (Wash D C) |
Title: |
Striatal CDK5 Regulates Cholinergic Neuron Activation and Dyskinesia-like Behaviors through BK Channels. |
Volume: |
6 |
|
Pages: |
0121 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ino H |
Year: |
1996 |
Journal: |
Brain Res |
Title: |
Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. |
Volume: |
732 |
Issue: |
1-2 |
Pages: |
179-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qi GJ |
Year: |
2016 |
Journal: |
Mol Neurobiol |
Title: |
Phosphorylation of Connexin 43 by Cdk5 Modulates Neuronal Migration During Embryonic Brain Development. |
Volume: |
53 |
Issue: |
5 |
Pages: |
2969-2982 |
|
•
•
•
•
•
|
Publication |
First Author: |
He X |
Year: |
2011 |
Journal: |
Neurochem Res |
Title: |
Hypomyelination phenotype caused by impaired differentiation of oligodendrocytes in Emx1-cre mediated Cdk5 conditional knockout mice. |
Volume: |
36 |
Issue: |
7 |
Pages: |
1293-303 |
|
•
•
•
•
•
|
Publication |
First Author: |
Samuels BA |
Year: |
2007 |
Journal: |
Neuron |
Title: |
Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. |
Volume: |
56 |
Issue: |
5 |
Pages: |
823-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Contreras-Vallejos E |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice. |
Volume: |
9 |
Issue: |
3 |
Pages: |
e90363 |
|
•
•
•
•
•
|
Publication |
First Author: |
Uribe-Arias A |
Year: |
2016 |
Journal: |
J Neurochem |
Title: |
p120-catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer's disease. |
Volume: |
138 |
Issue: |
4 |
Pages: |
624-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang KH |
Year: |
2012 |
Journal: |
J Cell Sci |
Title: |
Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death. |
Volume: |
125 |
Issue: |
Pt 21 |
Pages: |
5124-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Utreras E |
Year: |
2014 |
Journal: |
J Neuroinflammation |
Title: |
Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality. |
Volume: |
11 |
|
Pages: |
28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Asada A |
Year: |
2012 |
Journal: |
J Cell Sci |
Title: |
Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. |
Volume: |
125 |
Issue: |
Pt 14 |
Pages: |
3421-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Posada-Duque RA |
Year: |
2015 |
Journal: |
J Neurochem |
Title: |
p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing. |
Volume: |
134 |
Issue: |
2 |
Pages: |
354-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JH |
Year: |
2007 |
Journal: |
J Cell Sci |
Title: |
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. |
Volume: |
120 |
Issue: |
Pt 13 |
Pages: |
2259-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu AK |
Year: |
2013 |
Journal: |
Neurosignals |
Title: |
Cdk5 phosphorylates a component of the HDAC complex and regulates histone acetylation during neuronal cell death. |
Volume: |
21 |
Issue: |
1-2 |
Pages: |
55-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xie Z |
Year: |
2003 |
Journal: |
Cell |
Title: |
Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. |
Volume: |
114 |
Issue: |
4 |
Pages: |
469-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yip YP |
Year: |
2007 |
Journal: |
J Comp Neurol |
Title: |
Cdk5 selectively affects the migration of different populations of neurons in the developing spinal cord. |
Volume: |
503 |
Issue: |
2 |
Pages: |
297-307 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sasamoto K |
Year: |
2017 |
Journal: |
Dev Neurobiol |
Title: |
Cdk5 is required for the positioning and survival of GABAergic neurons in developing mouse striatum. |
Volume: |
77 |
Issue: |
4 |
Pages: |
483-492 |
|
•
•
•
•
•
|
Publication |
First Author: |
Castro-Alvarez JF |
Year: |
2014 |
Journal: |
Front Aging Neurosci |
Title: |
Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer's mice. |
Volume: |
6 |
|
Pages: |
243 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo F |
Year: |
2018 |
Journal: |
Exp Neurol |
Title: |
Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory. |
Volume: |
306 |
|
Pages: |
92-104 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sasaki Y |
Year: |
2002 |
Journal: |
Neuron |
Title: |
Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. |
Volume: |
35 |
Issue: |
5 |
Pages: |
907-20 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7608354 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2024-03-04 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3265122 |
Pattern: |
Regionally restricted |
Stage: |
TS22 |
Assay Id: |
MGI:7608366 |
Age: |
embryonic day 14.5 |
|
Note: |
Diminished levels of cell death observed in the Hm mutant limb correlated with diminished Cdk5 signal. |
Specimen Label: |
3-4 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
Publication |
First Author: |
He Y |
Year: |
2007 |
Journal: |
Glia |
Title: |
The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte. |
Volume: |
55 |
Issue: |
6 |
Pages: |
573-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van den Haute C |
Year: |
2001 |
Journal: |
Neurobiol Dis |
Title: |
Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. |
Volume: |
8 |
Issue: |
1 |
Pages: |
32-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee MH |
Year: |
2013 |
Journal: |
J Neurovirol |
Title: |
Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation. |
Volume: |
19 |
Issue: |
5 |
Pages: |
418-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nishimura YV |
Year: |
2014 |
Journal: |
Development |
Title: |
Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons. |
Volume: |
141 |
Issue: |
18 |
Pages: |
3540-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saito T |
Year: |
2013 |
Journal: |
J Biol Chem |
Title: |
Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators. |
Volume: |
288 |
Issue: |
45 |
Pages: |
32433-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li W |
Year: |
2016 |
Journal: |
J Neurosci |
Title: |
p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. |
Volume: |
36 |
Issue: |
44 |
Pages: |
11283-11294 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sadleir KR |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease. |
Volume: |
287 |
Issue: |
10 |
Pages: |
7224-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miller N |
Year: |
2023 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy. |
Volume: |
120 |
Issue: |
47 |
Pages: |
e2300308120 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohara-Imaizumi M |
Year: |
2010 |
Journal: |
PLoS One |
Title: |
Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. |
Volume: |
5 |
Issue: |
12 |
Pages: |
e15553 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen D |
Year: |
2022 |
Journal: |
Transl Neurodegener |
Title: |
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease. |
Volume: |
11 |
Issue: |
1 |
Pages: |
27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Husson H |
Year: |
2016 |
Journal: |
Hum Mol Genet |
Title: |
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis. |
Volume: |
25 |
Issue: |
11 |
Pages: |
2245-2255 |
|
•
•
•
•
•
|